Bangi Inc.

BNGI

US05989W1036

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 09:45:49 2024-04-24 am EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2020	Bangi Inc. Announces Executive Changes	CI
2019	Bangi Inc. Launches Acquisition Strategy with Purchase of Cannabis Processing Facility	CI

Bangi Investments, LLC acquired Compass Biotechnologies Inc..

November 15, 2018

Bangi I Bangi Investments, LLC acquired Compass Biotechnologies Inc. (OTCPK:COBI) on November 16, 2018. BANGI will trade as OTC:COBI until approval for its unique ticker symbol. Bangi Investments, LLC completed the acquisition of Compass Biotechnologies Inc. (OTCPK:COBI) on November 16, 2018.

Latest news about Bangi Inc.

Bangi Inc. Announces Executive Changes	20-05-26	CI
Bangi Inc. Launches Acquisition Strategy with Purchase of Cannabis Processing Facility	19-08-06	CI
BANGI, Inc. Appoints Mathew Knowles as Chief Marketing Officer	19-07-22	CI
Bangi Inc. Announces Executive Changes	19-07-08	CI
Bangi Inc. will Change its Ticker to BNGI from COBI	19-07-03	CI
BANGI Inc. Appoints Willard L Jackson to Board of Directors	18-12-14	CI
Compass Biotechnologies Inc. Keeps Rick Shykora as its Interim CEO	18-11-25	CI
Bangi Investments, LLC acquired Compass Biotechnologies Inc..	18-11-15	CI
Compass Biotechnologies Inc. cancelled the acquisition of efsAUDIO Inc.	17-02-04	CI
Compass Biotechnologies Inc. agreed to acquire efsAUDIO Inc.	16-02-04	CI
1WorldDirect Ltd. cancelled the acquisition of One World Direct Holdings Inc. from Compass Biotechnologies Inc..	15-02-10	CI
1WorldDirect Ltd. signed an Asset Purchase Agreement to acquire One World Direct Holdings Inc. from Compass Biotechnologies Inc..	14-02-10	CI
Compass Biotechnologies Inc. acquired 1World Direct Holdings Inc. for $1 million.	12-05-02	CI

Chart Bangi Inc.

Duration

Period

More charts

Company Profile

Bangi Inc. is focused on the acquisition, ownership and management of properties leased to experienced, state-licensed operators for regulated use of Cannabis facilities. The Company intends to acquire properties through sale-leaseback transactions and third-party purchases.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
BANGI INC.	0.00%	8.06K
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine

Bangi Inc.

Equities

BNGI

US05989W1036

Pharmaceuticals

Bangi Investments, LLC acquired Compass Biotechnologies Inc..

Latest news about Bangi Inc.

Chart Bangi Inc.

Company Profile

Sector Alternative Medicine